Summary
This case study details the challenges faced by a leading pharmaceutical company regarding its mature breast cancer therapy, which began losing market share due to increased competition and promotional pressure. The company's executives sought to determine the effectiveness of their promotional spending and whether the brand's return on investment (ROI) remained viable. The COVID-19 pandemic further complicated the situation by limiting traditional engagement channels. To address these issues, the company utilized IQVIA's ChannelDynamics, which integrated promotional activity data with sales performance metrics. This approach allowed the brand team to benchmark their market success against competitors and analyze ROI over time. The study outlines how the combination of ChannelDynamics and MIDAS provided a clear, data-driven confirmation of the brand's robust ROI, despite market challenges. Additionally, the implementation of the GMI Agent facilitated intuitive analytics and visualizations, helping brand leaders make informed strategic decisions regarding promotional investments.
